Compare INFU & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INFU | EARN |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.4M | 200.3M |
| IPO Year | N/A | 2013 |
| Metric | INFU | EARN |
|---|---|---|
| Price | $8.63 | $5.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $14.50 | $5.88 |
| AVG Volume (30 Days) | 118.2K | ★ 343.8K |
| Earning Date | 03-03-2026 | 03-11-2026 |
| Dividend Yield | N/A | ★ 17.17% |
| EPS Growth | ★ 271.43 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $141,054,000.00 | $35,893,000.00 |
| Revenue This Year | $8.82 | $8.43 |
| Revenue Next Year | $2.90 | $17.28 |
| P/E Ratio | $33.35 | ★ N/A |
| Revenue Growth | 6.23 | ★ 43.30 |
| 52 Week Low | $4.61 | $4.33 |
| 52 Week High | $11.04 | $6.82 |
| Indicator | INFU | EARN |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 61.47 |
| Support Level | $8.34 | $5.23 |
| Resistance Level | $8.82 | $5.64 |
| Average True Range (ATR) | 0.36 | 0.11 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 42.96 | 72.63 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.